γ-interferon signaling in pancreatic β-cells is persistent but can be terminated by overexpression of suppressor of cytokine signaling-1

Diabetes

Volumn 50, Issue 12, 2001, Pages 2744-2751

  Chong, Mark M W ^a   Thomas, Helen E ^a   Kay, Thomas W H ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CYTOKINE; DNA BINDING PROTEIN; DNA BINDING PROTEINS; GAMMA ACTIVATED FACTOR, 91 KD; GAMMA INTERFERON; GAMMA-ACTIVATED FACTOR, 91-KD; LUCIFERASE; MESSENGER RNA; SOCS 1 PROTEIN; SOCS-1 PROTEIN; TRANS ACTIVATORS; TRANSACTIVATOR PROTEIN;

ANIMAL; ARTICLE; CELL CULTURE; CELL DEATH; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; INSULINOMA; KINETICS; METABOLISM; MOUSE; MOUSE MUTANT; MOUSE STRAIN; PANCREAS ISLET; PANCREAS TUMOR; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMAL; CARRIER PROTEINS; CELL DEATH; CYTOKINES; DNA-BINDING PROTEINS; GENE EXPRESSION; INSULINOMA; INTERFERON TYPE II; ISLETS OF LANGERHANS; KINETICS; LUCIFERASE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; PANCREATIC NEOPLASMS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035656193     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.12.2744     Document Type: Article

References (47)

1. Campbell IL, Oxbrow L, West J, Harrison LC: Regulation of MHC protein expression in pancreatic beta-cells by interferon-γ and tumour necrosis factor-α. Mol Endocrinol 2:101-107, 1988
2. Eizirik DL, Flodstrom M, Karlsen AE, Welsh N: The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 39:875-890, 1996
3. Stassi G, Maria RD, Trucco G, Rudert W, Testi R, Galluzzo A, Giordano C, Trucco M: Nitric oxide primes pancreatic β cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med 186:1193-1200, 1997
4. Thomas HE, Darwiche R, Corbett JA, Kay TWH: Evidence that β cell death in the nonobese diabetic mouse is Fas independent. J Immunol 163:1562-1569, 1999
5. Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P: IL-1α, IL-1β, and IFN-γ mark β cells for Fas-dependent destruction by diabetogenic CD4+ T lymphocytes. J Clin Invest 105:459-468, 2000
6. Campbell IL, Iscaro A, Harrison LC: IFN-γ and tumor necrosis factor-α: cytotoxicity to murine islets of Langerhans. J Immunol 141:2325-2329, 1988
7. Pukel C, Baquerizo H, Rabinovitch A: Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferon-γ, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 37:133-136, 1988
8. Eizirik DL, Sandler S, Welsh N, Cetkovic-Cvrlje M, Nieman A, Geller DA, Pipeleers DG, Bendtzen K, Hellerstrom C: Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 93:1968-1974, 1994
9. Rabinovitch A, Suarez-Pinzon WL, Shi Y, Morgan AR, Bleackley RC: DNA fragmentation is an early event in cytokine-induced islet beta-cell destruction. Diabetologia 37:733-738, 1994
10. Corbett JA, McDaniel ML: Intraislet release of interleukin 1 inhibits β cell function by inducing β cell expression of inducible nitric oxide synthase. J Exp Med 181:559-568, 1995
11. Stephens LA, Thomas HE, Li M, Grell M, Darwiche R, Volodin L, Kay TWH: Tumor necrosis factor-α-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic β-cells. Endocrinology 140:3219-3227, 1999
12. Seewaldt S, Thomas HE, Ejrnaes M, Christen U, Wolfe T, Rodrigo E, Coon B, Michelsen B, Kay TW, von Herrath MG: Virus-induced autoimmune diabetes: most β-cells die through inflammatory cytokines and not perform from autoreactive (anti-viral) cytotoxic T-lymphocytes. Diabetes 49:1801-1809, 2000
13. Thomas HE, Parker JL, Schreiber RD, Kay TW: IFN-γ action on pancreatic beta cells causes class I MHC upregulation but not diabetes. J Clin Invest 102:1249-1257, 1998
14. Kanagawa O, Xu G, Tevaanverk A, Vaupel BA: Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-γ receptor loci. J Immunol 164:3919-3923, 2000
15. Platanias LC, Fish EN: Signaling pathways activated by interferons. Exp Hematol 27:1583-1592, 1999
16. Shuai K, Schindler C, Prezioso VR, Darnell JE Jr: Activation of transcription by IFN-γ: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258:1808-1812, 1992
17. Haspel RL, Salditt-Georgieff M, Darnell JE Jr: The rapid inactivation of nuclear tyrosine phosphorylated Stal1 depends upon a protein tyrosine phosphatase. Embo J 15:6262-6268, 1996
18. Schmid SL: Clathrin-coated vesicle formation and protein sorting: an integrated process. Annu Rev Biochem 66:511-548, 1997
19. Starr R, Hilton DJ: Negative regulation of the JAK/STAT pathway. Bioessays 21:47-52, 1999
20. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ: A family of cytokine-inducible inhibitors of signalling. Nature 387:917-921, 1997
21. Sakamoto H, Yasukawa H, Masuhara M, Tanimura S, Sasak IA, Yuge K, Ohtsubo M, Ohtsuka A, Fujita T, Ohta T, Furukawa Y, Iwase S, Yamada H, Yoshimura A: A Janus kinase inhibitor, JAB, is an interferon-γ-inducible gene and confers resistance to interferons. Blood 92:1668-1676, 1998
22. Song MM, Shuai K: The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J Biol Chem 273:35056-35062, 1998
23. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A: A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921-924, 1997
24. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T: Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924-929, 1997
25. Nicholson SE, Willson TA, Farley A, Starr R, Zhang JG, Baca M, Alexander WS, Metcalf D, Hilton DJ, Nicola NA: Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J 18:375-385, 1999
26. Yasukawa H, Misawa H, Sakamoto H, Masuhara M, Sasaki A, Wakioka T, Ohtsuka S, Imaizumi T, Matsuda T, Ihle JN, Yoshimura A: The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J 18:1309-1320, 1999
27. Conaway JW, Kamura T, Conaway RC: The Elongin BC complex and the von Hippel-Lindau tumor suppressor protein. Biochim Biophys Acta 1377:M49-M54, 1998
28. Zhang J, Farley A, Nicholson SE, Willson TA, Zugaro LM, Simpson RJ, Moritz RL, Cary D, Richardson R, Hausmann G, Kile BJ, Kent SB, Alexander WS, Metcalf D, Hilton DJ, Nicola NA, Baca M: The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci U S A 96:2071-2076, 1999
29. Chen G, Hohmeier E, Gasa R, Vien Tran V, Newgard CB: Selection of insulinoma cell lines with resistance to interleukin-1β and γ-interferon-induced cytotoxicity. Diabetes 49:562-570, 2000
30. Chen G, Hohmeier HE, Newgard CB: Expression of the transcription factor STAT-1α in insulinoma cells protects against cytotoxic effects of multiple cytokines. J Biol Chem 276:766-772, 2001
31. Heitmeier MR, Scarim AL, Corbett JA: Prolonged STAT1 activation is associated with interferon-γ priming for interleukin-1-induced inducible nitric oxide synthase expression by islets of Langerhans. J Biol Chem 274:29266-29273, 1999
32. Nicolet CM, Paulnock DM: Promoter analysis of an interferon-inducible gene associated with macrophage activation. J Immunol 152:153-162, 1994
33. Schreiber E, Matthias P, Muller MM, Schaffner W: Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res 17:6419, 1989
34. Nicholson SE, Novak U, Ziegler SF, Layton JE: Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK. Blood 86:3698-3704, 1995
35. Nicoletti I, Migliorati G, Pagliacci MC, Grignani G, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279, 1991
36. Heitmeier MR, Scarim AL, Corbett JA: Interferon-γ increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1. J Biol Chem 272:13697-13704, 1997
37. Naka T, Matsumoto T, Narazaki M, Fujimoto M, Morita Y, Ohsawa Y, Saito H, Nagasawa T, Uchiyama Y, Kishimoto T: Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc Natl Acad Sci U S A 95:15577-15582, 1998
38. Starr R, Metcalf D, Elefanty AG, Brysha M, Willson TA, Nicola NA, Hilton DJ, Alexander WS: Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc Natl Acad Sci U S A 95:14395-14399, 1998
39. Alexander WS, Starr R, Fenner JE, Scott CL, Handman E, Sprigg NS, Corbin JE, Cornish AL, Darwiche R, Owczarek CM, Kay TWH, Nicola NA, Hertzog PJ, Metcalf D, Hilton DJ: SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 96:597-608, 1999
40. Marine J-C, Topham DJ, McKay C, Wang D, Parganas E, Stravopodis D, Yoshimura A, Ihle JN: SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98:609-616, 1999
41. Saito H, Morita Y, Fujimoto M, Narazaki M, Naka T, Kishimoto T: IFN regulatory factor-1 mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 gene promoter by IFN-γ. J Immunol 164:5833-5843, 2000
42. Yamada K, Takane-Gyotoku N, Yuan X, Ichikawa F, Inada C, Nonaka K: Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia 39:1306-1312, 1996
43. Brysha M, Zhang JG, Bertolino P, Corbin JE, Alexander WS, Nicola NA, Hilton DJ, Starr R: Suppressor of cytokine signalling-1 attenuates the duration of interferon γ signal transduction in vitro and in vivo. J Biol Chem 276:22086-22089, 2001
44. Metcalf D, Alexander WS, Elefanty AG, Nicola NA, Hilton DJ, Starr R, Mifsud S, Di Rago L: Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1. Leukemia 13:926-934, 1999
45. Cottet S, Dupraz P, Hamburger F, Dolci W, Jaquet M, Thorens B: SOCS-1 protein prevents Janus Kinase/STAT-dependent inhibition of β cell insulin gene transcription and secretion in response to interferon-γ. J Biol Chem 276:25862-25870, 2001
46. Losman JA, Chen XP, Hilton D, Rothman P: SOCS-1 is a potent inhibitor of IL-4 signal transduction. J Immunol 162:3770-3774, 1999
47. Morita Y, Naka T, Kawazoe Y, Fujimoto M, Narazaki M, Nakagawa R, Fukuyama H, Nagata S, Kishimoto T: Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor α-induced cell death in fibroblasts. Proc Natl Acad Sci U S A 97:5405-5410, 2000